BioCentury
ARTICLE | Clinical News

AeroDose albuterol: Began Phase II testing

January 16, 2001 8:00 AM UTC

AeroGen Inc. (AEGN), Sunnyvale, Calif. Product: AeroDose albuterol Business: Drug delivery Therapeutic category: Receptor antagonist Target: Beta adrenergic receptors Description: Inhaled albuterol u...